Clinical Trial Update: Phase I Safety and Immunogenicity of Live Attenuated Influenza H5 Candidate Vaccine Strain A/17/Turkey/Turkey/05/133 (H5N2) in Healthy Thai Volunteers [Phase 1]

View source ↗

Summary

This Phase I, completed study evaluated the safety and immunogenicity of a live attenuated H5 avian influenza vaccine candidate (A/17/Turkey/Turkey/05/133, H5N2…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Avian Influenza

Drugs mentioned

• Live Attenuated Influenza H5 Candidate Vaccine Strain A/17/Turkey/Turkey/05/133 (H5N2)

Snippet

Sponsor: Mahidol University | Conditions: Preventive Avian Flu | Phase 1 | Status: COMPLETED